Armistice Capital »

Portage Biotech shares owned by Armistice Capital

Quarter-by-quarter ownership of Portage Biotech (PRTG) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Portage Biotech

Tip: Access up to 7 years of quarterly data

All positions including Portage Biotech held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Portage Biotech by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.1M 2.0M 2.09

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Portage Biotech

Lakeview Capital Partners
Citadel Advisors
Beacon Investment Advisory Services
Ieq Capital
Sigma Planning
Dimensional Fund Advisors
Pathstone Holdings
Barclays
Royal Bank of Canada
National Bank Of Canada /fi/
Wells Fargo & Company
CWM
Princeton Global Asset Management
UBS Group

View all funds holding Portage Biotech